Helixbind, Inc
HelixBind, Inc., based in Boxborough, MA, is pioneering an innovative diagnostic platform aimed at transforming the care of bloodstream infections. Their proprietary technology delivers faster, more accurate, and informative microbiology results, enabling clinicians to precisely identify invasive infections and tailor antimicrobial interventions for patients.
Addressing the critical challenge of sepsis, which affects millions globally, HelixBind's platform provides results in just four hours compared to the traditional blood culture tests that take up to 23 days. By facilitating rapid identification and characterization of infections, the company aims to improve patient outcomes and combat the spread of antimicrobial resistance.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.